Test Predicts Response to Key Migraine Therapy With 86% Accuracy
Researchers from Harvard Medical School found non-ictal cephalic allodynia, established by a quick, inexpensive and noninvasive proprietary test, is an 86% accurate pretreatment predictor of anti-calcitonin gene–related peptide (CGRP) therapy response. To read the rest of the article head over to PainMedicineNews.com
More to explorer
Emotional Awareness, Expression Therapy Shown to Curb Pain Severity
Facebook A randomized clinical trial’s results suggest that emotional awareness and expression therapy (EAET) “may be a preferred intervention for medically and psychiatrically complex
Psychosocial Distress May Be Best Indicator of High-Impact Chronic Pain With KOA
Facebook Data published in the Journal of Pain indicate that high-impact chronic pain (HICP) is more common among people with knee osteoarthritis (KOA)
Trim the Fat, Reduce the Pain?
Facebook A first-of-its-kind study has found a link between carrying extra fat in the gut and widespread chronic pain, with reductions in